Short-term intravenous insulin infusion is associated with reduced expression of NADPH oxidase p47(phox) subunit in monocytes from type 2 diabetes patients

Details

Serval ID
serval:BIB_24AB252A40E0
Type
Article: article from journal or magazin.
Collection
Publications
Title
Short-term intravenous insulin infusion is associated with reduced expression of NADPH oxidase p47(phox) subunit in monocytes from type 2 diabetes patients
Journal
Fundam Clin Pharmacol
Author(s)
Vaquer G., Magous R., Cros G., Wojtusciszyn A., Renard E., Chevassus H., Petit P., Lajoix A. D., Oiry C.
ISSN
1472-8206 (Electronic)
ISSN-L
0767-3981
Publication state
Published
Issued date
12/2013
Volume
27
Number
6
Pages
669-71
Language
english
Notes
Vaquer, Guillaume
Magous, Richard
Cros, Gerard
Wojtusciszyn, Anne
Renard, Eric
Chevassus, Hughes
Petit, Pierre
Lajoix, Anne-Dominique
Oiry, Catherine
eng
Clinical Trial
England
Fundam Clin Pharmacol. 2013 Dec;27(6):669-71. doi: 10.1111/j.1472-8206.2012.01057.x. Epub 2012 Jul 10.
Abstract
Hyperglycemia is a well-known inducing factor of oxidative stress through activation of NADPH oxidase. In addition to its plasma glucose lowering effect, insulin may also have antioxidant activity and was shown to downregulate NADPH oxidase expression in vitro. In this study, we show that a short-term (3-day) intravenous insulin infusion in patients with type 2 diabetes induces normalization of both glycemia and mRNA expression of circulating monocyte p47(phox) subunit.
Keywords
Blood Glucose/drug effects, Case-Control Studies, Diabetes Mellitus, Type 2/*drug therapy, Gene Expression Regulation/drug effects, Humans, Hypoglycemic Agents/administration & dosage/*pharmacology, Infusions, Intravenous, Insulin/administration & dosage/*pharmacology, Middle Aged, Monocytes/drug effects/metabolism, NADPH Oxidases/*genetics, RNA, Messenger/metabolism, Time Factors, NADPH oxidase, diabetes, insulin, monocytes
Pubmed
Create date
14/06/2021 9:59
Last modification date
18/09/2021 6:38
Usage data